Comparison between intravenous prostaglandin E2 and extraamniotic prostaglandin F2α instillation for termination in second-trimester pregnancy

Journal of Maternal-Fetal Investigation

Volumn 8, Issue 3, 1998, Pages 134-138

  Lee, Chien Nan ^a   Cheng, Wen Fang ^a   Lai, Hong Ling ^a   Shyu, Ming Kwang ^a   Chen, Tzer Ming ^a   Wu, Ruey Tsong ^a   Shih, Jin Chung ^a   Hsieh, Fon Jou ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Prostaglandin e2; Prostaglandin f2 ; Second trimester pregnancy termination

Indexed keywords

PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; SULPROSTONE;

ABDOMINAL DISCOMFORT; ADULT; ARTICLE; BLOOD TRANSFUSION; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; FEMALE; FEVER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; NAUSEA; PREGNANCY TERMINATION; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; SWEATING; TIME; VERTIGO; VOMITING;

EID: 0031692224     PISSN: 09396322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Gastadot RG. Pregnancy termination: Techniques, risk, complications, and their management. Fertil Steril 1986;45:5-17.
2. Barr MM. Mid-trimester abortion: 12 to 20 weeks by dilatation and evacuation method under local anesthesia. Adv Plann Parent 1978;13:16-20.
3. Peterson WF, Berry FN, Grace MR, Gulbranson CL. Second-trimester abortion by D&E: An analysis of 11,747 cases. Obstet Gynecol 1983;62:185-90.
4. Kajanoja P. Induction of abortion by prostaglandin in the second trimester of pregnancy. Acta Obstet Gynecol Scand 1983;! 13:145-51.
5. Karim SM, Filshie GM. Therapeutic abortion using prostaglandin F2a. Lancet 1970;!: 157-59.
6. Hochman M, Laufe LE. Midtrimester pregnancy termination with prostaglandin E2 vaginal suppositories. J Reprod Med 1976; 15:26368.
7. Bygdeman M, Kwon SU, Mukherjee T, Wigvist N. Effect of intravenous infusion of prostaglandin E[ and E2 on motility of the pregnant human uterus. Am J Obstet Gynecol 1968;102:317-26.
8. Lebed JP. Comparison between intraamniotic PGF2 and vaginal PGE2a for second-trimester abortion. Obstet Gynecol 1980;56:90-5.
9. Wingerup L, Ekman G, Ulmsten U. Local application of prostaglandin E2 in gel. Acta Obstet Gynecol Scand 1983;! 13:131-36.
10. Krishna U, Ganguli AC, Mandlekar AV, Purandare VN. Administration of prostaglandin by various routes for induction of abortion: Merits and demerits. Prostaglandins 1978; 15:685-93.
11. Hill NCW, Mackenzie IZ. 2,308 second-trimester terminations using extraamniotic or intraamniotic prostaglandin E2: An analysis of efficacy and complication. Br J Obstet Gynaecol 1989;96:1424-31.
12. Amorn K, Supron K. Comparative study on the use of intravenous and intramuscular sulprostone for pregnancy termination. Proceedings, 2nd Asian Symposium on Prostaglandin and Sulprostone. 1986:49-57.
13. Luengo J, Keirse MJNC, Nennebroek GJ. Extraamniotic prostaglandin F2ci for intrauterine death and fetal abnormality. Eur J Obstet Gynecol Reprod Biol 1977:7:325-29.
14. Kaplan EL, Meier P. Non-parametric estimation form: Incomplete observations. J Am Stat Assoc 1958;53:457-81.
15. Cox DR. Regression model and life tables. J Stat Soc 1972;34:187220.
16. Rslow NE, Day NE. Statistical methods in cancer research. Lyon Int Agency Res Cancer. 1987;2:120-76.
17. Borgida AF, Rodis JF, Hanlon W. Second-trimester abortion by intramuscular 15-methylprostaglandin F2 or intravaginal prostaglandin E2 suppositories: A randomized trial. Obstet Gynecol 1995;85:697-700.
18. Abramovici H, Bornstein J, Ben-Eavid YD. Double-balloon instillation device for second-trimester abortion. J Reprod Med 1995;40:5662.
19. Winkler CL, Gray SE, Hauth JC, Owen J, Tucker JM. Mid-secondtrimester labor induction: Concentrated oxytocin compared with prostaglandin E2 vaginal suppositories. Obstet Gynecol 1991;77:297-300.
20. Peggy JS, Jack AP. Oxytocin and water intoxication. JAMA 1963; 186:601-3.
21. Papageorgiou I, Minaretzis D, Tsionou C, Michalas S. Late midtrimester medical pregnancy terminations: Three different procedures with prostaglandin F2a and laminaria tents. Prostaglandin 1991;41: 487-93.
22. Karim SM, Sharma SD. Therapeutic abortion and induction of labor by the intravaginal administration of prostaglandin E2 and F2a. J Obstet Gynaecol Br Comm 1971;78:294-300.
23. Humphrey HHK, Marc JNK. Low-dose sulprostone for pregnancy termination in cases of fetal abnormality. Prenat Diag 1993; 13:117-21.